NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmerican Eagle ( AEO) upgraded at Sterne Agee to Buy. $27 price target. Estimates also boosted, as new management initiatives should drive growth. Advanced Micro ( AMD) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Valuation call, as the stock is down 49% over the past year. $3.50 price target. Amgen ( AMGN) upgraded at UBS from Neutral to Buy, UBS said. $96 price target. Expect better near-term clinical data. Ariad Pharmaceuticals ( ARIA) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $26 price target. Expect continued strong clinical data in the near term. Biogen Idec ( BIIB) downgraded at UBS from Buy to Neutral, UBS said. $156 price target. Valuation call, as the stock is up 56% from the last upgrade. Bemis ( BMS) rated new Neutral at JPMorgan. $37 price target. Lagging fundamentals balance cash generation story. Brocade Communications Systems ( BRCD) upgraded to buy at TheStreet Ratings. Colony Financial ( CLNY) downgraded to hold at TheStreet Ratings. Celgene ( CELG) downgraded at UBS from Buy to Neutral, UBS said. $80 price target. Valuation call, as the stock is up 27% since Revlimid was not approved in the EU. Cliffs Natural ( CLF) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $39 price target. Estimates also cut, given lower expected iron ore prices and rising costs. Carpenter Technology ( CRS) upgraded at JPMorgan to Overweight from Neutral, JPMorgan said. $70 price target. Sustainable growth in materials. Dover ( DOV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call. Amdocs ( DOX) downgraded at Jefferies to Hold from Buy, Jefferies said. $35 price target. Full valuation. Exelon ( EXC) downgraded at Citigroup from Neutral to Sell, Citigroup said. $31 price target. Estimates also cut, given higher expected costs. Fifth Third Bancorp ( FITB) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Catalyst achieved. Fulton Financial ( FULT) upgraded at Sterne Agee to Buy from Hold, Sterne Agee said. $11.50 price target. Attractive valuation. Hubbell ( HUB.B) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already factoring in a late-stage economic recovery. International Paper ( IP) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $39 price target. Stock is already pricing in a potential price hike, which may not yet materialize.